653 related articles for article (PubMed ID: 36906600)
1. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies.
Shi ZD; Pang K; Wu ZX; Dong Y; Hao L; Qin JX; Wang W; Chen ZS; Han CH
Signal Transduct Target Ther; 2023 Mar; 8(1):113. PubMed ID: 36906600
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B; Sajeev A; Vishwa R; Aswani BS; Alqahtani MS; Abbas M; Kunnumakkara AB
Cancer Metastasis Rev; 2024 Mar; 43(1):321-362. PubMed ID: 38517618
[TBL] [Abstract][Full Text] [Related]
4. Tumor Plasticity and Resistance to Immunotherapy.
Horn LA; Fousek K; Palena C
Trends Cancer; 2020 May; 6(5):432-441. PubMed ID: 32348738
[TBL] [Abstract][Full Text] [Related]
5. The great escape: tumour cell plasticity in resistance to targeted therapy.
Boumahdi S; de Sauvage FJ
Nat Rev Drug Discov; 2020 Jan; 19(1):39-56. PubMed ID: 31601994
[TBL] [Abstract][Full Text] [Related]
6. Cellular Plasticity in Cancer.
Yuan S; Norgard RJ; Stanger BZ
Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
[TBL] [Abstract][Full Text] [Related]
7. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of tumor cell plasticity in modifying therapeutic response.
Qin S; Jiang J; Lu Y; Nice EC; Huang C; Zhang J; He W
Signal Transduct Target Ther; 2020 Oct; 5(1):228. PubMed ID: 33028808
[TBL] [Abstract][Full Text] [Related]
9. HER2 in stemness and epithelial-mesenchymal plasticity of breast cancer.
Voutsadakis IA
Clin Transl Oncol; 2019 May; 21(5):539-555. PubMed ID: 30306401
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.
Vig N; Mackenzie IC; Biddle A
J Oral Pathol Med; 2015 Oct; 44(9):649-55. PubMed ID: 25594908
[TBL] [Abstract][Full Text] [Related]
11. Cellular plasticity and drug resistance in sarcoma.
Lin Z; Fan Z; Zhang X; Wan J; Liu T
Life Sci; 2020 Dec; 263():118589. PubMed ID: 33069737
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in Cancer Cell Plasticity.
Xu J; Liu S
Adv Exp Med Biol; 2016; 927():173-89. PubMed ID: 27376735
[TBL] [Abstract][Full Text] [Related]
13. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
14. EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.
Tulchinsky E; Demidov O; Kriajevska M; Barlev NA; Imyanitov E
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):29-39. PubMed ID: 30419315
[TBL] [Abstract][Full Text] [Related]
15. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance.
Mondal P; Meeran SM
Cancer Metastasis Rev; 2024 Mar; 43(1):135-154. PubMed ID: 37707749
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell plasticity: Impact on tumor progression and therapy response.
da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
Liu T; Han C; Fang P; Zhu H; Wang S; Ma Z; Zhang Q; Xia W; Wang J; Xu L; Yin R
Cell Mol Life Sci; 2021 Mar; 78(5):1983-2000. PubMed ID: 33170304
[TBL] [Abstract][Full Text] [Related]
19. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
